Home CONTACT Neoplasma 2013 Neoplasma Vol.60, No.2, p.135-142, 2013

Journal info

6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.60, No.2, p.135-142, 2013

Title: Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma
Author: J. QI, J. WANG, H. KATAYAMA, S. SEN, S. M. LIU

Abstract: Incidence and mortality associated with hepatocellular carcinoma (HCC) is rising throughout the world. Accurate, noninvasive biomarkers for the early detection of HCC are urgently needed to reduce worldwide morbidity and mortality related to HCC. MicroRNAs (miRNAs), 17- to 25-nucleotide noncoding RNAs that are frequently dysregulated in HCC, have shown great promise as tissue-based markers for HCC diagnosis and prognosis. Moreover, they are stably expressed in serum and urine, and these circulating microRNAs (cmiRNAs) are emerging as novel noninvasive biomarkers for the early detection and prognosis of HCC. This article summarizes the latest findings on the role of circulating miRNAs as potential minimally invasive diagnostic and prognostic biomarkers for HCC.

Keywords: circulating microRNAs (cmiRNAs), biomarkers, HCC, diagnosis and prognosis
Published online: 26-Nov-2012
Year: 2013, Volume: 60, Issue: 2 Page From: 135, Page To: 142

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.